ARTICLE | Clinical News
H5N1 VLP vaccine: Phase II started
June 17, 2013 7:00 AM UTC
Medicago began a placebo-controlled Phase II trial to evaluate its intramuscular H5N1 VLP vaccine plus an alum adjuvant or Glucopyranosyl Lipid A (GLA-AF) adjuvant in 390 healthy adults ages 18-60 yea...